Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, reposted from Mater Dei General Hospital on LinkedIn:
”Would you take a life-saving drug knowing that in one case out of three this does not work? Probably not.
In the heart of Rome, one of the first centers in Italy to finally offer the possibility of predicting the response to the most widely used anti-caking drug, clopidogrel, with a simple and rapid genetic test.
The result of the test is integrated with the most up-to-date international recommendations on the subject, to which I had the honor of contributing, to offer a personalized assessment and improve the prognosis of patients in each specific clinical context.
After years of scientific research, it is time to turn science into real benefits for a more targeted and personalized care of cardiovascular patients.”
Mater Dei General Hospital shared on LinkedIn:
”What is the Genomadix Cube test?
It is a simple and non-invasive genetic test that helps to understand how our body responds to some fundamental drugs in cardiology, such as antiplatelet drugs that inhibit P2Y12 (clopidogrel, prasugrel or ticagrelor)
Let’s find out more with Dr. Mattia Galli
Info and reservations
Tel. 06 83 803”
Read the full article in JACC.
Article: International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Authors: Dominick J. Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L. Bhatt, Laurent Bonello, Davide Capodanno, Larisa H. Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi, Tobias Geisler, C. Michael Gibson, Diana A. Gorog, Paul A. Gurbel, Young-Hoon Jeong, Rossella Marcucci, Jolanta M. Siller-Matula, Roxana Mehran, Franz-Josef Neumann, Naveen L. Pereira, Konstantinos D. Rizas, Fabiana Rollini, Derek Y.F. So, Gregg W. Stone, Robert F. Storey, Udaya S. Tantry, Jurrien Ten Berg, Dietmar Trenk, Marco Valgimigli, Ron Waksman, Dirk Sibbing
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 11:50Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
-
Mar 12, 2026, 11:44Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia
-
Mar 12, 2026, 11:33Kymentie Ferdinande: New Insights Into Platelet Function and Thrombus Formation in Cirrhosis
-
Mar 12, 2026, 11:17Tareq Abadl: Why Do Some People Bruise And Bleed So Easily?
-
Mar 12, 2026, 11:15Matthew Flick: The Interplay of the Fibrinogen αC-Region, Hypofibrinogenemia, and GPVI in Arterial Thrombosis
-
Mar 12, 2026, 11:08Stephen Twumasi: The Impact of Hepatitis B Infection on the Coagulation System During Pregnancy
-
Mar 12, 2026, 11:05Robert Lufkin: One Minute of Wisdom from Robert Lustig on Cholesterol, Sugar, and Heart Disease
-
Mar 12, 2026, 10:36Cynthia Dunbar: Retiring From NIH After 39 Years to Advance Advocacy and Research in Hematology
-
Mar 11, 2026, 23:05Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority